Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma-Reference-Cited by-同舟云学术

Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma

Published:2021-01-26 Issue:9 Volume:40 Page:1659-1673
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Schäfer Alexander,Haenig Benedicte,Erupathil Julie,Strickner Panja,Sabato Daniela,Welford Richard W. D.,Klaeylé Lhéanna,Simon Elise,Krepler Clemens,Brafford Patricia,Xiao Min,Herlyn Meenhard^ORCID,Gstaiger Matthias^ORCID,Lehembre Francois,Renz Imke^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-020-01628-x.pdf

Reference44 articles.

1. Barton M, Yanagisawa M. Endothelin: 20 years from discovery to therapy. Can J Physiol Pharm. 2008;86:485–98.

2. Rosano L, Spinella F, Bagnato A. Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2013;13:637–51.

3. Yohn JJ, Smith C, Stevens T, Hoffman TA, Morelli JG, Hurt DL, et al. Human melanoma cells express functional endothelin-1 receptors. Biochem Biophys Res Commun. 1994;201:449–57.

4. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000;406:536–40.

5. Demunter A, De Wolf-Peeters C, Degreef H, Stas M, van den Oord JJ. Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch. 2001;438:485–91.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The journey from melanocytes to melanoma;Nature Reviews Cancer;2023-04-24

2. Consensus Clustering and Survival-Related Genes of Cuproptosis in Cutaneous Melanoma;Mediators of Inflammation;2023-02-27

3. RAMP: response-aware multi-task learning with contrastive regularization for cancer drug response prediction;Briefings in Bioinformatics;2022-12-02

4. The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness;Frontiers in Oncology;2022-05-10

5. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1;Theranostics;2022